New hope for sickle cell pain? hospital tests oral ketamine for youth in crisis
NCT ID NCT05378555
Summary
This study is testing if adding an oral form of the drug ketamine to standard pain medications can better control the severe pain of sickle cell crises in hospitalized adolescents and young adults. It aims to see if this approach is practical and safe for patients aged 12-24 who are admitted to the hospital for a pain crisis. The goal is to find a better way to manage this intense pain that often doesn't respond well to high doses of opioid painkillers alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASO-OCCLUSIVE CRISIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Boston Children's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.